97 related articles for article (PubMed ID: 17594598)
1. Impact of cytokines on the pathomechanism of diabetic and alcoholic neuropathies.
Michałowska-Wender G; Adamcewicz G; Wender M
Folia Neuropathol; 2007; 45(2):78-81. PubMed ID: 17594598
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte transketolase activity in patients with diabetic and alcoholic neuropathies.
Michalak S; Michałowska-Wender G; Adamcewicz G; Wender MB
Folia Neuropathol; 2013; 51(3):222-6. PubMed ID: 24114639
[TBL] [Abstract][Full Text] [Related]
3. Associations of serum anti-ganglioside antibodies and inflammatory markers in diabetic peripheral neuropathy.
Ge S; Xie J; Zheng L; Yang L; Zhu H; Cheng X; Shen F
Diabetes Res Clin Pract; 2016 May; 115():68-75. PubMed ID: 27242125
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of cytokines in painful and painless neuropathies.
Uçeyler N; Rogausch JP; Toyka KV; Sommer C
Neurology; 2007 Jul; 69(1):42-9. PubMed ID: 17606879
[TBL] [Abstract][Full Text] [Related]
5. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy.
Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
Diabetes Metab Syndr; 2014; 8(1):48-52. PubMed ID: 24661759
[TBL] [Abstract][Full Text] [Related]
6. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy.
Misur I; Zarković K; Barada A; Batelja L; Milicević Z; Turk Z
Acta Diabetol; 2004 Dec; 41(4):158-66. PubMed ID: 15660198
[TBL] [Abstract][Full Text] [Related]
8. Possible contribution of adipocytokines on diabetic neuropathy.
Matsuda M; Kawasaki F; Inoue H; Kanda Y; Yamada K; Harada Y; Saito M; Eto M; Matsuki M; Kaku K
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S121-3. PubMed ID: 15563961
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function.
Kallestrup M; Møller HJ; Tankisi H; Andersen H
Diabet Med; 2015 Jan; 32(1):54-61. PubMed ID: 25156085
[TBL] [Abstract][Full Text] [Related]
10. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies.
Trojaborg W; Hays AP; van den Berg L; Younger DS; Latov N
Muscle Nerve; 1995 Jul; 18(7):730-5. PubMed ID: 7540258
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of pro-inflammatory cytokines in diabetic patients with peripheral neuropathic pain and the correlation among them].
Yu LN; Yang XS; Hua Z; Xie W
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):469-71. PubMed ID: 19567096
[TBL] [Abstract][Full Text] [Related]
12. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
Nybo M; Poulsen MK; Grauslund J; Henriksen JE; Rasmussen LM
Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491
[TBL] [Abstract][Full Text] [Related]
13. Low serum levels of nerve growth factor in diabetic neuropathy.
Faradji V; Sotelo J
Acta Neurol Scand; 1990 May; 81(5):402-6. PubMed ID: 2375241
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 and tumor necrosis factor-alpha as diagnostic biomarkers for diabetic peripheral neuropathy.
Zhu T; Meng Q; Ji J; Lou X; Zhang L
Neurosci Lett; 2015 Jan; 585():28-32. PubMed ID: 25445373
[TBL] [Abstract][Full Text] [Related]
15. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
Jarmuzewska EA; Ghidoni A
Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
[TBL] [Abstract][Full Text] [Related]
16. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration.
Skundric DS; Lisak RP
Exp Diabesity Res; 2003; 4(4):303-12. PubMed ID: 14668051
[TBL] [Abstract][Full Text] [Related]
17. [Predictors for diabetic neuropathy according to applied criteria of its diagnosis].
Gryz EA; Szermer P; Galicka-Latała D; Sieradzki J; Szczudlik A
Przegl Lek; 2002; 59(11):881-4. PubMed ID: 12715713
[TBL] [Abstract][Full Text] [Related]
18. The Association between Serum Cytokines and Damage to Large and Small Nerve Fibers in Diabetic Peripheral Neuropathy.
Magrinelli F; Briani C; Romano M; Ruggero S; Toffanin E; Triolo G; Peter GC; Praitano M; Lauriola MF; Zanette G; Tamburin S
J Diabetes Res; 2015; 2015():547834. PubMed ID: 25961054
[TBL] [Abstract][Full Text] [Related]
19. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
[TBL] [Abstract][Full Text] [Related]
20. Diabetic neuropathy: prevalence, concordance between clinical and electrophysiological testing and impact of risk factors.
Sangiorgio L; Iemmolo R; Le Moli R; Grasso G; Lunetta M
Panminerva Med; 1997 Mar; 39(1):1-5. PubMed ID: 9175413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
